Loss of SMARCB1 evokes targetable epigenetic vulnerabilities in Epithelioid Sarcoma
Jia Xiang Jin, Fabia Fuchslocher, Martha Julia Carreño-Gonzalez, Felina Zahnow, A. Katharina Ceranski, Rainer D. Will, Dominic Helm, Felix Bestvater, Ana Banito, Roland Imle, Shunya Ohmura, Florencia Cidre‐Aranaz, Thomas G. P. Grünewald
This study investigates how SMARCB1 loss in Epithelioid Sarcoma rewires epigenetic regulation, revealing therapeutic vulnerabilities through functional multi-omics analysis.
癌症:英文版 · Jan 20, 2025Peer-reviewedCancer Biology